Kent Imaging Inc.

Kent Imaging Inc. is a medical device company specializing in near-infrared spectroscopy (NIRS) imaging technology for wound care and tissue assessment. The company manufactures two primary portable diagnostic devices: SnapshotNIR, which non-invasively measures tissue oxygenation levels in wounds to assess perfusion and viability, and SnapshotGLO, which assesses bacterial bioburden at the bedside. These devices are designed for use in wound care management, reconstructive surgery, and clinical settings where tissue assessment is critical for treatment decisions. The SnapshotNIR device has been validated in clinical use on over 4,000 wounds and is employed to guide debridement decisions, monitor healing progression, and confirm graft viability post-operatively. SnapshotGLO addresses infection risk by enabling non-invasive bacterial assessment without invasive sampling. Together, the Snapshot Suite provides dual imaging insights to reduce diagnostic uncertainty, support earlier targeted interventions, and optimize wound healing outcomes. Kent Imaging has demonstrated 20 years of continuous innovation in NIRS medical imaging technology. The company serves wound care centers, acute care hospitals, reconstructive surgery programs, and clinical institutions requiring portable, real-time tissue assessment capabilities. Products are used in settings ranging from acute trauma management to chronic wound care optimization.